Results: 4

1.

Figure. From: Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.

Fig 4 Cumulative hazard (or cumulative detection rate) of CIN 2 among women invited for cervical screening by age group at randomisation and by screening arm

Maarit K Leinonen, et al. BMJ. 2012;345:e7789.
2.

Figure. From: Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.

Fig 3 Cumulative hazard (or cumulative detection rate) of CIN 1 among women invited for cervical screening by age group at randomisation and by screening arm

Maarit K Leinonen, et al. BMJ. 2012;345:e7789.
3.

Figure. From: Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.

Fig 2 Cumulative hazard (or cumulative detection rate) of CIN 3 or AIS among women invited for cervical screening by age group at randomisation and by screening arm

Maarit K Leinonen, et al. BMJ. 2012;345:e7789.
4.

Figure. From: Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.

Fig 1 Flowchart of the screening profiles of women invited for cervical screening in the Finnish HPV screening trial in 2003-07. ICC=invasive cervical cancer. Data after semi colons are number of women who were not screened according to their random allocation

Maarit K Leinonen, et al. BMJ. 2012;345:e7789.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk